Objective; This study aimed to explore practices among healthcare professionals in nonsteroidal anti-inflammatory drug (NSAID) information provision.
Introduction
Nonsteroidal anti-inflammatory drugs (NSAIDs) are in widespread use for pain and inflammatory conditions. Many are accessible without a prescription, especially in pharmacy settings, where NSAIDs are frequently purchased. [1] [2] [3] [4] [5] However, there are potentially serious long-term risks associated with using NSAIDs, in addition to the well-known side effects, about which those using these medicines should be informed. [6, 7] Studies in many countries
show that awareness of side effects and risks associated with NSAIDs among those who use them is poor. [1, 3, 4, [8] [9] [10] [11] [12] [13] [14] In Thailand, more than in many other countries, this group of drugs is widely available since they can be purchased without prescription from pharmacies, and
NSAIDs are extensively used. [15] Not surprisingly therefore, NSAIDs are consistently reported to the Thai Food and Drug Administration (Thai FDA) as the second most frequent cause of adverse effects. [16] Our previous surveys have shown that both hospital pharmacists (HPs) and orthopedic physicians (OPs) in Thailand have positive attitudes towards the provision of information to patients about the risks associated with NSAIDs. [17, 18] Approximately 75% of OPs and 84%
of HPs claimed to provide patients with information about side effects, mainly gastrointestinal problems, and over 80% of both groups saw patient information leaflets (PILs) provided with medicines as appropriate useful sources for improving risk and benefit information. Our community pharmacist (CP) survey found that most claimed to screen patients for factors which could increase NSAID risks when supplying non-selective COX-2
NSAIDs, but did so less often if supplying selective NSAIDs. [19] They were also less likely to provide information and advice about side effects with supply of selective NSAIDs than for non-selective drugs. [19] Patients on the other hand have indicated that, while the majority receive information about how to use NSAIDs and their indication, fewer than half report receiving information about side effects and they perceive the risks of NSAIDs as generally 4 low. [20] The findings from this survey do however concur with those of health professionals, in that attitudes towards receiving written information in the form of PILs were positive. [21] Such leaflets are not however widely available in Thailand, despite evidence that they can improve patient knowledge of medicines. [22] A small survey of PILs for NSAIDs in community pharmacies showed that these are not generally available for locally manufactured generic products. [23] The majority of leaflets which were available were aimed at prescribers, not patients and none conformed to Thai regulatory requirements.
A US study found that physicians and pharmacists are the information sources regarding NSAID risks that most NSAID users prefer to access, [24] while almost all Thai patients considered both professional groups had a role to play in providing information about ADRs. [21] Moreover, studies in the US and Canada show that both play major roles in communicating with patients to improve their awareness of these risks and their recommendations can affect patients' choices in purchasing an NSAID over the counter. [9, 10] Other US studies have found that, in practice, only half of the elderly who were prescribed NSAIDs received counseling from healthcare providers at their last consultation, [25] and that the majority of healthcare providers only provide some details about medication to patients, with administration being given priority over warnings about adverse effects and risks. [26] One survey, in Greece, attributed low awareness of possible NSAID risks in patients with comorbidity, especially those at risk of cardiovascular events, to insufficient communication between patients and healthcare professionals. [14] However, our surveys of Thai health professionals have identified a range of factors affecting self-reported information provision in addition to the type of NSAID. These include work setting, number of work colleagues, time available for direct patient contact and gender. [17] [18] [19] Our patient survey also found that the duration of NSAID use and age were factors which affected whether or not they had received information about potential side effects and how to avoid or manage these.
[20] Some of the practices appeared inappropriate in the light of current knowledge of NSAID risks. For example, younger patients reported receiving information more frequently than older patients and intermittent users more than regular users, [20] while community pharmacists advocated differing management of side effects depending on type of NSAID. [19] Thus it appears that studies in different countries find that not all important issues about NSAIDs are communicated to all patients, especially risk information, yet no qualitative studies have attempted to gain an insight into why this may be the case. We therefore sought to gain more understanding of the factors which affect the provision of information on these medicines by health professionals.
The aim of this study was to explore decision-making, prioritization and reasons for this in relation to provision of information to patients about the risks of NSAID among orthopedic physicians, hospital pharmacists and community pharmacists, and to assess similarities and differences among these groups.
Methods

Study design and setting
This qualitative research was conducted using in-depth interviews, which were carried out by one researcher over a five-month period (May-August 2015 
Participants
Three groups of healthcare professionals that share responsibility for providing NSAIDs to patients in practice were included to explore their perceived roles in also providing information about NSAIDs: OPs, HPs and CPs. Purposive sampling was used to identify 60 potential participants, 20 in each group. In each province, two hospitals and two community pharmacies were purposively selected, to include in each province, representation of both urban and rural areas, and for community pharmacies a Thai Pharmacy Council accredited and non accredited pharmacy. Community pharmacies which did not supply both nonselective and selective NSAID products, and rural hospitals which had no OPs were excluded. Potential participants were invited to take part and to make an appointment for interview by telephone. We identified the participants by convenient sampling from selected sites. The target recruited healthcare professionals in each site consisted of 2 pharmacists and 2 orthopedic physicians. If a participant could not be recruited from the selected site, another participant at the same site would be approached to achieve the target number. However, if there was only one participant (physician) working at the site, we selected only one participant. A letter was sent to all those who verbally indicated they were willing to participate, confirming the interview appointment.
Interview content
A guideline for the interview was developed to elicit individuals' experiences of providing information about NSAIDs to their patients, to gain insight into the risk information given.
The topic guideline was based on literature review and gaps found in previous studies.
[ [17] [18] [19] The guideline was assessed for face validity by three pharmacists, who confirmed that it represented the study objectives, and any minor problems revised before collecting data. The topics included were: details of NSAID information provided to patients, with emphasis on adverse effects; criteria used for screening and selecting patients for prescribing or supply of NSAIDs; and opinions on provision of NSAID risk information to patients.
Data collection
Face-to-face semi-structured interviews were conducted in Thai language with consented participants, at their place of work, or other location chosen by participants. All were audiorecorded with consent. The researcher recorded reflections on the interviews as field notes immediately after each interview.
Data analysis
All interview records along with the field notes were transcribed in Thai by Researcher 1, and transcripts re-checked for accuracy by researcher 2. Next, the transcripts were translated into English, and the accuracy of translation was checked first by researcher 2, then checked independently by researcher 3. Initially, the data were subjected to framework analysis to develop codes, based on the themes in the interview guideline. Researcher 1 and researcher 2 independently read and generated subthemes from transcripts, and all generated subthemes were discussed and agreed upon. Following this, the emergent sub-themes with new codes were discussed by all researchers. Finally, the data were summarized into overarching themes.
Results
A total of 51 healthcare professionals agreed to participate in the study: 13 OPs (response rate 65%), 20 HPs (100%), ten working mainly in out-patient units and ten in in-patient units, and 8 all participants were female, with both hospital and community pharmacists having a majority of females. In contrast, only two of the 13 physicians were female. Age distribution also differed between the groups, with half of the community pharmacists being under 30 years of age, in contrast to only two of the physicians, and physicians had less work experience than the pharmacists.
(Insert Table 1 Information was provided in general about NSAIDs, as well as safety information and that there were differences regarding the information given depending on whether patients were attending their first visit or a follow-up, and the type of NSAID (non-selective NSAIDs or selective COX-2 NSAIDs). The themes and subthemes are described below, with illustrative quotes identified by participant type and number.
Theme 1: General information related to NSAIDs
Under this theme, participants talked about the information they gave to patients concerning the indication for the NSAID, its selection and administration, including duration.
-Subtheme 1: How to take this drug
The majority of both HPs (14) and CPs (15) claimed that they provided general information to patients, but this seemed to be less common practice among OPs (4). Most who did said they did not give special attention to patients receiving NSAIDs, except advice on taking after meals. This was only covered by two CPs, one of whom specified the abnormal symptoms that meant patients should return.
"I informed patients about "If you frequently feel burning sensation in your stomach, you should come back to any community pharmacy to receive gastro-protective drugs" (CP_005, accredited pharmacy)
Theme 3: Differences between new NSAID users and regular NSAID users
Ten of those interviewed said their practice was the same for both patients receiving an NSAID for the first time and those who were regular users. HPs claimed it was difficult to distinguish between these groups, but some OPs also indicated they did not vary the information provided.
"It is similar in providing information in all cases. In prescription of NSAIDs, I advise patients to take drug when they have symptoms and do not take it every day." (OP_010, community hospital) -Subtheme 1: Amount of information
In contrast, 15 (eight HPs, four CPs and three OPs) described differences, some indicating that they provided more detailed information for new NSAID users and others that increasing information was given with longer duration of use. Differences in the provision of safety information related to NSAIDs dependent on whether patients received non-selective NSAID users and selective NSAID users was highlighted by many participants, but eleven (six HPs, three CPs and two OPs) said they offer the same information regardless of NSAID type.
"I informed only if this was new drug group or older, …because mostly customers
were not interested in depth of these details." (CP_001, non-accredited pharmacy)
-Subtheme 1: Side effects
Other participants did claim to provide different information, especially for GI side effects, with thirteen (six HPs, two CPs, five OPs) explaining to patients about reduced incidence of GI side effects in selective NSAIDs. This confidence in the reduced potential for problems extended as far as some providing no information.
"When patients were prescribed a new group of NSAIDs, I informed about this drug had lower GI side effects but for safety patients should take it after meals" (HP_005, general hospital)
In contrast, three specifically informed patients about CV problems with selective NSAIDs (two CPs and one OP) and one on renal effects.
"I told openly to them that this drug [celecoxib] had side effect on heart. When I informed them, they feel accepted and well-understood. They were not anxious to discontinue." (OP_006, community hospital)
-Subtheme 2: Drug costs
In addition to information about potential side effects, two CPs also mentioned providing information about drug costs.
"For a new class of NSAIDs, their prices were very high with less side effects. I have to clarify patients about this drug choice. The decision was up to the customer.
(CP_018, accredited pharmacy)
Discussion
Information communicated to patients using NSAIDS varied between different health professionals, but also depended on type of NSAID and duration of use. Pharmacists in both 14 hospital and community provided general information on administration and indication, which was consistent with our previous survey of NSAID users, a high proportion of whom reported receiving such information. [21] However, the present study suggests physicians did not always offer this information, which may contribute to the apparent confusion, mentioned by some pharmacists.
Although most interviewees claimed they informed patients of adverse effects, this was selective, as has been found elsewhere, [9, 11] emphasising GI complications. This was also reflected in our survey of NSAID users, fewer than half of whom recalled receiving information about adverse effects. [21] Reasons given for providing selected information varied, but included trading, time available, patients' age and their perceived ability to understand. Many did not discuss additional risks with their patients, raising concerns that such information may lead to lower adherence in some patients, which confirmed previous findings from our surveys of Thai HPs and OPs. [17, 18] While ideally all NSAID users should be informed about all potential adverse effects, realistically this may be difficult in practice. Hence varying the amount of information given to different patient groups may be a useful strategy. Perceptions that too much information could reduce understanding, or affect adherence have been expressed by health professionals in Thailand and elsewhere. [17, 18, 27] The health professionals in our study managed potential information overload by providing information on renal and CV risks only to patients requesting this information, or to selected groups, such as the elderly or those with underlying disease. Reserving detailed discussion of less common side effects and longer term risks for regular NSAID users, as was the practice of some participants, also seems reasonable and has been reported elsewhere.
[28]
The practice we found of expounding lower GI side effects with selective NSAIDs while not informing about other issues, and indeed failing to inform patients of potential adverse effects to influence their purchasing decision, is less justifiable. This is of particular concern for patients receiving healthcare through the UCS and SHI health schemes, who can receive free medicines from the National Essential Medicines List, including non-selective
NSAIDs, but not selective NSAIDs, for which they must pay. This practice may lead the public to believe that selective NSAIDs are better and safer to use. Clearly type of NSAID was a factor affecting other aspects of information provision, again confirming some of our survey results. [19, 20] CV side effects were only mentioned by a few participants in relation to selective NSAIDs and not with non-selective drugs, despite similar risks. [6] The cost of obtaining different NSAIDs, of immediate relevance to purchasers, was an additional aspect of information provision related to type of NSAID, and also affected decisions about selection by OPs and CPs.
Explaining the need to avoid duplicating NSAIDs was mentioned by only two interviewees, despite the potentially dangerous combination of prescription and nonprescription NSAIDs being widespread. [26] Few interviewees referred to the need to avoid NSAIDs or use them short-term in older people or to exercise caution in patients with risk factors or concomitant drug use which could increase their chances of adverse events. [3, 4, 12, 13, 20, [29] [30] [31] The potential for acute effects on the kidney [7] were only discussed in long-term users.
Patients value healthcare professionals as important sources of information, even though in many countries other sources can be easily accessed. [22, 32, 33] Although the failure to inform patients in full about risks may reasonably be related to decisions about the quantity of information, when to provide it and its necessity in short term users, there is a need for greater provision. Written information provided with all purchased medicines, as occurs elsewhere, would give all users of NSAIDs accessible risk information, regardless of NSAID type, duration of use or patient characteristics. 16 This study was limited to five of the 77 provinces in Thailand. The majority of pharmacists in our study were female, in contrast to the physicians, who were mostly male and the age distribution and work experience differed between pharmacists and physicians, most likely due to the time taken to qualify for the latter positions. As with any qualitative study the results cannot be generalized to healthcare practice in Thailand more widely.
Moreover, the interviews required participants to generalize their practices and the information they gave was subject to recall bias and could not be verified. Although we were not able to undertake validation of the transcriptions or seek interviewee views on our interpretation, all interviews were reviewed by two researchers and themes discussed by all authors.
Conclusion
The content and frequency of information provision varied between health professionals and was affected by duration and type of NSAID, as well as patient factors. Pharmacists provided general information more than physicians and, while all three groups discussed side effects, they mostly concentrated on GI effects. Important information about potential drug-drug interactions, other adverse effects and how to monitor for these was often overlooked.
Greater attention should be paid by all health professions to providing information about NSAID risks to help reduce adverse events. The provision of PILs with medicines could improve available information for patients. 
